Elanco Wins USDA Approval for TruCan Ultra Lyme-L4 Vaccine
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
Animal Health
Advertisement
FDA Approves KEYTRUDA-WELIREG Combination for High-Risk Kidney Cancer Patients
RAHWAY, N.J., June 12, 2026 The U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™...
FDA Authorizes First Generic Treatment for New World Screwworm
SILVER SPRING, Maryland, June 11, 2026 The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization...
Jazz Reports Phase 3 Success for Ziihera in HER2+ GEA
DUBLIN, Ireland, May 27, 2026 Jazz Pharmaceuticals has announced the publication of pivotal Phase 3 HERIZON-GEA-01 trial results in...
Innocan Pharma Reports Strong Q1 Growth and Pipeline Progress
HERZLIYA, Israel and CALGARY, Alberta, May 27, 2026 Innocan Pharma Corporation has reported strong first-quarter 2026 financial results, highlighting...
Advertisements
Boehringer Ingelheim Reveals Hidden Global Impact of Veterinary Care
Ingelheim, Germany, May 25, 2026 Boehringer Ingelheim has unveiled new findings from a large international veterinary survey revealing the...
Elanco Launches Befrena for Canine Allergy and Itch Relief
Indianapolis, Indiana, USA – May 18, 2026 Elanco Animal Health Incorporated announced the phased U.S. launch of Befrena™ (tirnovetmab),...
Galvanize Expands Aliya PEF Portfolio With FDA Clearance of Aliya EX
REDWOOD CITY, Calif., May 18, 2026 Galvanize Therapeutics has announced that the U.S. Food and Drug Administration (FDA) granted...
Dechra Wins FDA Approval for Canine CosACTHen®
OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...
Servier’s Emi-Le Earns FDA Breakthrough Status
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Advertisement
